TherapeuticsMD
TXMD
#10499
Rank
โ‚น2.30 B
Marketcap
โ‚น198.91
Share price
0.00%
Change (1 day)
101.82%
Change (1 year)

Revenue for TherapeuticsMD (TXMD)

Revenue in 2026 (TTM): โ‚น0.29 Billion

According to TherapeuticsMD's latest financial reports the company's current revenue (TTM ) is โ‚น0.32 Billion. In 2025 the company made a revenue of โ‚น0.27 Billion an increase over the revenue in the year 2024 that were of โ‚น0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for TherapeuticsMD from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น0.29 B10.25%
2025 โ‚น0.27 B79.57%
2024 โ‚น0.15 B39.38%
2023 โ‚น0.10 B-48.61%
2022 โ‚น0.21 B-96.74%
2021 โ‚น6.47 B36.41%
2020 โ‚น4.74 B34.01%
2019 โ‚น3.54 B214.5%
2018 โ‚น1.12 B5.08%
2017 โ‚น1.07 B-18.56%
2016 โ‚น1.31 B-1.74%
2015 โ‚น1.33 B40.56%
2014 โ‚น0.95 B75.66%
2013 โ‚น0.54 B159.35%
2012 โ‚น0.20 B9.17%
2011 โ‚น0.19 B20885.75%
2010 โ‚น0.91 M86.07%
2009 โ‚น0.49 M
2006 โ‚น44.52 M6.5%
2005 โ‚น41.8 M54.76%
2004 โ‚น27.01 M35.59%
2003 โ‚น19.92 M44.96%
2002 โ‚น13.74 M-14.35%
2001 โ‚น16.04 M-6.57%
2000 โ‚น17.17 M84.69%
1999 โ‚น9.29 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Pfizer
PFE
โ‚น6.113 T 1,888,179.15%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น6.065 T 1,873,416.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Agile Therapeutics
AGRX
โ‚น2.08 B 543.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น235.65 B 72,686.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
โ‚น29.99 B 9,165.40%๐Ÿ‡บ๐Ÿ‡ธ USA